By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Rosetta Genomics today said that the New York State Department of Health has granted the firm approval to begin processing patient samples from the state for its miRview mets^2 test.

New York requires providers of laboratory-developed tests to receive approval from the state to process samples from patients within the state. It's the only state in the union to require that independent regulatory review process.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.